All Programs

Use the tool below to view all available AXISMedEd Activities

Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CE
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
0.25 credits
- Kathleen N. Moore, MD, MS
0.25 credits
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CE
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
0.25 credits
- Jean Hoffman-Censits, MD
0.25 credits
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CE
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD
0.25 credits
- Joseph Kim, MD, MPH, MBA, FACHE
- Samir Dalia, MD
- Christopher Jurief
0.25 credits
Chairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
Chairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
CME/CE
Chairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
Adam Brufsky, MD, PhD
0.25 credits
- Adam Brufsky, MD, PhD
0.25 credits
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CE
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Harry Erba, MD, PhD
1.00 credit
- Harry Erba, MD, PhD
1.00 credit
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Benjamin Levy, MD
0.25 credits
- Benjamin Levy, MD
0.25 credits
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
CME/CE
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
Taofeek K. Owonikoko, MD, PhD
0.25 credits
- Taofeek K. Owonikoko, MD, PhD
0.25 credits
Optimizing Multidisciplinary Approaches in the Guideline-Driven Management of Cervical and Endometrial Cancers
Optimizing Multidisciplinary Approaches in the Guideline-Driven Management of Cervical and Endometrial Cancers
CME/CE Broadcast Replay
Optimizing Multidisciplinary Approaches in the Guideline-Driven Management of Cervical and Endometrial Cancers
Brian Slomovitz, MD
1.00 credit
- Brian Slomovitz, MD
1.00 credit
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
CME/CE
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
Reshma L. Mahtani, DO
0.25 credits
- Reshma L. Mahtani, DO
0.25 credits
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
CME/CE
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
Natasha B. Leighl, MD, MMSc
0.50 credits
- Natasha B. Leighl, MD, MMSc
0.50 credits
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CE
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Carlos M. de Castro, MD
0.50 credits
- Carlos M. de Castro, MD
0.50 credits
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
CME/CE
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
Jorge E. Cortes, MD
0.25 credits
- Jorge E. Cortes, MD
0.25 credits
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
CME/CE
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
Sara M. Tolaney, MD, MPH
0.25 credits
- Sara M. Tolaney, MD, MPH
0.25 credits
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
CME/CE
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
Michael J. Mauro, MD
0.25 credits
- Michael J. Mauro, MD
0.25 credits
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CE
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Mark Socinski, MD; Patrick Forde, M.B.B.Ch.
0.25 credits
- Mark Socinski, MD
- Patrick Forde, M.B.B.Ch.
- Karen Reckamp, MS, MD
0.25 credits
Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies
Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies
CME/CE
Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies
Ayse Tuba Kendi, MD; A. Oliver Sartor, MD
1.00 credit
- Ayse Tuba Kendi, MD
- A. Oliver Sartor, MD
1.00 credit

All Programs

Popular

Title